Kookmin Bio Co., Ltd.
PrivateLast Round
Series B
Nov 20, 2024
Total Funding Raised
$4.58M
Company Overview
Kookmin Bio Co., Ltd. is a biotechnology company that researches and develops bio-based food and pharmaceutical ingredients and microbiome-based new drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, D2C Brands, Sports & Fitness
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kookmin Bio Co., Ltd. Comparables
Compare Kookmin Bio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genome & Company | 66% | |
| Chong Kun Dang Holdings Corp. | 65% | |
| hy | 60% |
Kookmin Bio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 20, 2024 | ||||
| Series A | May 20, 2022 | ||||
| Pre Seed | Nov 19, 2021 |
Kookmin Bio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Alternative Asset Management | Series A, Series B |
| K-Ground Ventures | Series B |
| Kookmin University Technology Holding Co., Ltd. | Series A |
| New Paradigm Investment | Series A, Series B, Pre Seed |
| Industrial Bank of Korea | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2024
$3M round led by New Paradigm Investment.
- May 20, 2022
$1.58M round led by New Paradigm Investment.
Kookmin Bio Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kookmin Bio Co., Ltd.'s valuation, stock price, and market status.
Is Kookmin Bio Co., Ltd. a public or private company?
Kookmin Bio Co., Ltd. is a private company.
What is the current stock price of Kookmin Bio Co., Ltd.?
Kookmin Bio Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Kookmin Bio Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kookmin Bio Co., Ltd. worth (valuation)?
Valuation information for Kookmin Bio Co., Ltd. is not publicly available.
Can I buy Kookmin Bio Co., Ltd. stock?
Kookmin Bio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kookmin Bio Co., Ltd.'s last funding round?
Kookmin Bio Co., Ltd.'s most recent funding round was Series B on November 20, 2024.
Who are the main investors in Kookmin Bio Co., Ltd.?
Key investors in Kookmin Bio Co., Ltd. include New Paradigm Investment.
Will Kookmin Bio Co., Ltd. IPO soon?
No public IPO plans have been announced for Kookmin Bio Co., Ltd..
How can I track Kookmin Bio Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Kookmin Bio Co., Ltd.'s shares on secondary markets.